Browsing: Scaling

Over the past few years, the conversation around GLP-1 receptor agonists has been dominated by extremes: dramatic weight loss in clinical trials, before-and-after transformations on social media, and a public discourse that has oscillated between miracle and backlash. Patients are now asking pointed and more practical questions. Do I need the full dose if I only…